Our results demonstrated that inhibition of kynurenine 3-monooxygenase (KMO) profoundly ameliorated myocardial injury by maintaining mitochondrial fusion and fission balance, which may reveal a novel potential therapeutic strategy for myocardial ischemia. This evidence concerns the gene KMO and myocardial ischemia.